Moderna just posted an 11% surge with zero news behind it, while its longtime mRNA peer BioNTech can barely keep pace with the broader biotech sector. Something broke between these two names,…
Merck and Moderna just proved their cancer vaccine works, and the ripple effects reach far beyond either company. Five names stand to collect a toll on every single dose manufactured, but not…
Moderna just handed back 7% of its staggering year-to-date run in a single session, and the question rattling traders is whether this is a routine exhale or the beginning of a painful…
Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the options chain hints at why this whipsaw is far from over.
A historic one-session rally in a cancer vaccine stock is already unwinding, and Wall Street analysts disagree sharply on whether the reversal reflects a trade gone cold or an opportunity that the…
A single Phase 3 readout just shook the cancer treatment world, sending one biotech stock to its biggest single-day gain ever and forcing Wall Street to rethink whether personalized mRNA therapies have…
Moderna has already surged more than 80% in 2026, but two major events packed into the next two weeks could either cement that rally or unravel it fast.
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast. Moderna (NASDAQ: MRNA | MRNA Price Prediction) has fallen 58.2% over five years. BioNTech (NASDAQ: BNTX) is down 10.9%…
The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee trading on apps like Robinhood (NASDAQ:HOOD | HOOD Price Prediction) and Fidelity. Now, it no longer takes a…
Pfizer (NYSE:PFE | PFE Price Prediction) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster…
The Bill & Melinda Gates Foundation is one of the world’s biggest philanthropic organizations. Once the world’s richest man, Bill Gates has fallen to seventh on the list with a net worth…
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Thursday's top analyst upgrades and downgrades included Analog Devices, AppLovin, Goodyear Tire & Rubber, Home Depot, iQIYI, Knight-Swift Transportation, Kohl’s, Lowe's Companies, Marriott International, Nutrien, Tencent Music Group and Wynn Resorts.
A major media company reports results early Friday morning, while a biotech and a food products company will report before Monday's opening bell.
Tuesday's top analyst upgrades and downgrades included Alphabet, Caterpillar, Corning, Digital Realty Trust, Dish Network, KeyCorp, Nvidia, Pinterest, Roku, Tesla and Wynn Resorts.
